Trunome is a revolutionary non-invasive diagnostic test that enables the early detection and monitoring of chronic diseases through a blood test. Being the first and entirely made-in-India technology platform in Asia, it is protected by patents granted in the United States and is known for its high effectiveness and accuracy in monitoring organ health.
Trunome-Tx specializes in offering solutions for post-transplant patients organ health. An innovative diagnostic test called Trunome is a non-invasive method that helps in monitor status of solid organ transplants through a blood test.
An effective way to monitor the health of transplanted solid organs such as the kidney, liver, heart, lungs, and pancreas. The organization offers specialized care solutions to support post-transplant recovery and long-term health.
With innovation and technologies, we are tackling the most ambitious and complex challenges in healthcare by revolutionizing early diagnosis of chronic and infectious diseases. Our global team of dedicated scientists are united in the pursuit of solving moonshot challenges, striving to deliver improved clinical outcomes and positively impact lives.
The innovative RTLAMP technology provides Covid-19 results in less than one hour. COVIQWIK is a solution to make mass testing scalable and make public places safer.
Acrannolife’s core focus is on developing a technology platform for the detection and monitoring of chronic and infectious diseases, with the goal of disrupting the current process through early detection, decentralizing testing, and democratizing access to make it accessible to patients globally.